Xbrane is hosting a Virtual Capital Markets Day on May 17th, 2021
Stockholm, Sweden – Xbrane (Nasdaq: XBRANE), a late-stage clinical biopharma company is inviting analysts, investors and media to the company’s Virtual Capital Markets Day on May 17th, 2021 at 14.00-15.30 CET.
The event will feature presentations from Xbrane’s Board and Management team outlining the company strategy and the next steps in the company's ambition to become a leading global biosimilar developer. The program will also include a virtual show of the recently established new development lab.
The event will start at 14.00 and will be broadcast live.
Please register using the following link;
|Xbrane Biopharma||Anders Tullgren, Chairman|
|The Biosimilar Market||Martin Åmark, CEO|
|Xlucane™||Martin Åmark, CEO|
|Platform Technology & Capabilities||David Vikström, Head of R&D|
|Virtual tour of the new Biotech lab||Siavash Bashiri, Deputy CEO|
|A world-leading Biosimilar Developer||Martin Åmark, CEO|
|Wrap-up and Q&A session||Martin Åmark, CEO|
Agenda in brief:
Participants are invited to ask questions to IR@xbrane.com or live during the event.
Recordings of the presentations, and the presentations themselves, will be made available on the website www.xbrane.com.